5Chen W,Zhenguo Z.Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism:A Randomiz ed,Multicenter,Controlled Trial[J].Chest,2010,137(2):254-262. 被引量：1
二级参考文献13
1Areasory SM,Kreit JW.Thrombolytic therapy of pulmonary embolism:aeompreheansive review of current evidence[J].Chest,1999,6(8):1695. 被引量：1
2Kostadima E Zakynthinos E pulmonary embolism:pathophysiology,diagnosis,treatment[J].Hellenic J Cardiol,2007,48(2):94. 被引量：1
3Hamel E,Paconret G,Vincentelli D,et al.Thrombolysis or heparin therapy in massive pulmouary embolism with right ventrichular dilation results from a 128-patient monocenter registry[J].Chest,2001,120(1):120. 被引量：1
4Schoep UJ,Kucher N,Kipfmueller F,et al Right ventricular enlargement on chest computed tomography.A predictor of early deathinacutepulmonaryemblism[J].Circulation,2004,110(20):3276. 被引量：1
5Torbicki A,Perrier A,Konstantinides S,et al.Guidelines on the diagnosis and management of acute pulmonary embolism:the task force for the diagnosis and management of scute pulmonary embolism of the european society of cardiology(ESC)[J].Eur Heart J,2008,29(18):2276. 被引量：1
6Stewart RJ Fredenburgh JC,Leslie BA,et al.Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator[J].J Biolchem,2000,275(14):10112. 被引量：1
